Phase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinoma.
Kim HS, Kim SM, Kim H, Pyo KH, Sun JM, Ahn MJ, Park K, Keam B, Kwon NJ, Yun HJ, Kim HG, Chung IJ, Lee JS, Lee KH, Kim DJ, Lee CG, Hur J, Chung H, Park JC, Shin SK, Lee SK, Kim HR, Moon YW, Lee YC, Kim JH, Paik S, Cho BC.
Kim HS, et al. Among authors: keam b.
Oncotarget. 2015 Dec 29;6(42):44971-84. doi: 10.18632/oncotarget.6056.
Oncotarget. 2015.
PMID: 26462025
Free PMC article.
Clinical Trial.